Pharmacodynamic evaluation of a new glycopeptide, LY333328, and in vitro activity against Staphylococcus aureus and Enterococcus faecium.
The objectives of the present study were to compare the in vitro activity of LY333328 (LY) to that of vancomycin (V) alone and in combination with gentamicin (G) and rifampin (R) against methicillin-resistant Staphylococcus aureus (MRSA) and V-resistant Enterococcus faecium (VREF), by using the kill...
Zapisane w:
| Wydane w: | Antimicrob Agents Chemother |
|---|---|
| Główni autorzy: | , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
American Society for Microbiology (ASM)
1997
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163905/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9174189/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.41.6.1307 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|